Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment

Alzheimer’s Disease Neuroimaging Initiative

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences